[go: up one dir, main page]

MY142195A - Controlled-release compositions - Google Patents

Controlled-release compositions

Info

Publication number
MY142195A
MY142195A MYPI20034063A MY142195A MY 142195 A MY142195 A MY 142195A MY PI20034063 A MYPI20034063 A MY PI20034063A MY 142195 A MY142195 A MY 142195A
Authority
MY
Malaysia
Prior art keywords
controlled
release
matrix
agent
release compositions
Prior art date
Application number
Inventor
Lenaerts Vincent
Ouadji-Nkiki Patricia Laure
Bacon Jonathan
Ouzerourou Rachid
Gervais Sonia
Rahmouni Miloud
Smith Damon
Original Assignee
Labopharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labopharm Inc filed Critical Labopharm Inc
Publication of MY142195A publication Critical patent/MY142195A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A SOLID DOSAGE FORMULATION HAVING A CORE WITH A PHARMACOLOGICAL AGENT DISPERSED IN A FIRST CONTROLLED-RELEASE MATRIX FROM WHICH RELEASE OF THE AGENT IS RELATIVELY SLOW; AND A COAT FORMED OVER THE CORE AND HAVING THE AGENT DISPERSED IN A SECOND CONTROLLED-RELEASE MATRIX FROM WHICH RELEASE OF THE AGENT IS RELATIVELY FAST. THE FIRST MATRIX CAN BE A CROSS-LINKED HIGH AMYLOSE STARCH AND THE SECOND MATRIX CAN BE A MIXTURE OF POLYVINYL ACETATE AND POLYVINYLPYRROLIDONE.
MYPI20034063 2002-10-25 2003-10-25 Controlled-release compositions MY142195A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28102602A 2002-10-25 2002-10-25
US51000003P 2003-10-10 2003-10-10

Publications (1)

Publication Number Publication Date
MY142195A true MY142195A (en) 2010-10-15

Family

ID=44539364

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20034063 MY142195A (en) 2002-10-25 2003-10-25 Controlled-release compositions

Country Status (3)

Country Link
JP (1) JP4897930B2 (en)
IL (1) IL168113A (en)
MY (1) MY142195A (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2173818A1 (en) * 1996-04-10 1997-10-11 Francois Chouinard Time-released pharmaceutical compound containing a cured amylose-based support and hydroxypropylmethylcellulose
DE10015479A1 (en) * 2000-03-29 2001-10-11 Basf Ag Solid oral dosage forms with delayed release of active ingredient and high mechanical stability
US6607748B1 (en) * 2000-06-29 2003-08-19 Vincent Lenaerts Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture

Also Published As

Publication number Publication date
JP2011153154A (en) 2011-08-11
JP4897930B2 (en) 2012-03-14
IL168113A (en) 2013-04-30

Similar Documents

Publication Publication Date Title
SI1558935T1 (en) Controlled-release compositions
ES2101082T3 (en) CONTROLLED RELEASE COMPOSITIONS.
NZ515359A (en) Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol
NL2000281A1 (en) Solid pharmaceutical compositions containing pregabalin.
HK1051487A1 (en) Controlled-release compositions containing opioid agonist and antagonist
TWI235068B (en) Sustained-release pharmaceutical composition
MX9707585A (en) Homogeneous mixtures of low temperature-melting drugs and additives for controlled release.
ZA200509477B (en) Delayed release tablet with defined core geometry
GEP20074022B (en) Pharmaceutical formulations comprising oxycodone and naloxone
CA2457361A1 (en) Opioid agonist formulations with releasable and sequestered antagonist
AU3490300A (en) Dopamine agonists in combination with nitric oxide donors, compositions and methods of use
HRP20050625A2 (en) BUPROPION HYDROCHLORIDE TABLES WITH CHANGE-RELEASED
AR001405A1 (en) Oral formulation of 2-methyl-thieno-beno-diazepine.
CA2435729A1 (en) New film coating
WO2004064815A8 (en) Oral dosage formulation
PL2057984T3 (en) Retard tablets with hydromorphon
UA94917C2 (en) Topical formulations
CA2543353A1 (en) Oral drug delivery system
AU2002233271A1 (en) Substitued oxazoles and thiazoles as hppar alpha agonists
DE69512638D1 (en) FAST-RESOLUTION ORAL PHARMACEUTICAL FORM
MY142195A (en) Controlled-release compositions
UA86929C2 (en) Controlled-release compositions
WO2003034822A3 (en) Powdery active ingredient formulations
WO2007025182A3 (en) Drug compositions containing controlled release hypromellose matrices
WO2003051370A8 (en) Selective dopamine d3 receptor agonists for the treatment of sexual dysfunction